Rocuronium Bromide Injection, Solution
Product Images NDC 71872-7372

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7372.pdp (7372)

Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) multiple-dose vial label. It states the product is for intravenous use only, contains 10 mL vial quantity, and includes warnings for paralyzing agent effects and respiratory arrest. The label details storage instructions, mentions the vial is sterile and nonpyrogenic, and is distributed by Medical Purchasing Solutions, Scottsdale, AZ, made in India by Caplin Steriles USA, Inc.*

FDA Label Image

7372m.pdp (7372m)

Label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) multiple-dose vial for intravenous use. The label displays a warning indicating it is a paralyzing agent. The product is sterile and nonpyrogenic. It is manufactured by Caplin Steriles and distributed by Caplin Steriles USA Inc. Storage instructions require refrigeration between 2°C and 8°C. The label includes a barcode, lot, and expiration date fields.*

FDA Label Image

Caplin-logo (Caplin Logo)

FDA Label Image

Rcb-spl-structure (Rcb Spl Structure)

Chemical structure of rocuronium bromide showing its molecular arrangement with various rings and functional groups, including a quaternary ammonium group and bromide ion, consistent with the active ingredient rocuronium bromide.*

FDA Label Image

Rcb-spl-structure02 (Rcb Spl Structure02)

Box plot chart showing data on minutes plotted against dose in mg/kg for Rocuronium Bromide injection, segmented into age groups: 18-64 years, >=65 years, and 1-12 years. The chart depicts variability and outliers in response times across these groups and dosages.*

FDA Label Image

Rcb-spl-structure03 (Rcb Spl Structure03)

Box plot chart depicting minutes on the y-axis across different age groups and dosages of Rocuronium Bromide on the x-axis. Age groups include 18-64 years, 65 years and older, 3 months to 1 year, and 1-12 years, with dosages ranging from 0.45 mg/kg to 1.2 mg/kg. The graph shows variations and distribution of a time measure for intravenous Rocuronium Bromide injection across dosages and age groups.*

FDA Label Image

Rcb-spl-structure04 (Rcb Spl Structure04)

A line graph depicting the duration in minutes on the vertical axis and dose number on the horizontal axis, comparing two dosage levels of rocuronium bromide injection solution: 0.1 mg/kg and 0.15 mg/kg. The graph shows data points with sample sizes of N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg over five doses, illustrating differences in time duration at each dose number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.